期刊文献+

舒马曲坦等曲坦类药物致肠系膜缺血 被引量:2

原文传递
导出
摘要 曲坦类药物的不良反应,常见的为腹泻,偶见有便秘、吞咽困难、胃食管返流等。罕见的为胃肠道出血、呕血、黑便、消化性溃疡及腹部疼痛等。该类药物能否致结肠炎或肠道局部出血,尚未确定。 UMC数据库所收集的结肠炎报告中,有24份疑与舒马曲坦(sumatriptan)有关。
作者 王俊
出处 《药物不良反应杂志》 2002年第6期417-418,共2页 Adverse Drug Reactions Journal
  • 相关文献

同被引文献38

  • 1潘学田主编.中国药品实用手册2001年版[M].北京:中国石油工业出版社,2001年.B218-B219.
  • 2Pascual J,Falk R.,Docekal R., et al.Tolerability and efficacy of almotriptan in the long-term treatment of migraine.Eur Neurol,2001,45 (4) :206~213.
  • 3Cabarrocas X, Esbri IL, ILeris F, et al.Long-term efficacy and safety of oral almotfiptan:interim analysis of 1 -year open study.Headache,2001,41(1) :57~62.
  • 4Teall J,Tuchman M,Cutler N,et al.Rizatriptan for the acute treatment of migraine and migraine recurrenec.A placebo-controlled outpatient study.Headache,1998,38 (4) :281~287.
  • 5Anon J, Zolmitriptan.antimigaine 5-HT1B/1D receptoragonist.Drugs Future,1999,24 (3) :357~359.
  • 6Ferrari MD,Roon KI,Lipton RB,et al.Oral tripitans in acute migraine treatment:a meta-analysis of 53 trials.Lancent,2001,358 (9294) :1668~1675.
  • 7Keam SJ,Goa KL,Figgitt DP.Almotriptan,a review of its use in migraine.Drugs,2002,62 (2) :387-414.
  • 8Keam SJ,Goa KL, Figgitt DP.Almotriptan,a review of its use in migraine.Drugs,2002,62 (2) :387-414.
  • 9Goadsby PJ.5-HT 1B/1D receptor agonists in migraine comparative pharmacology and its therapeutic implications.CNS Drugs, 1998, 10 (4) :271~286.
  • 10Bou J,Gras J.Vascular effects of the new antimigraine agent almotriptan on human cranial and peripheral arteries.Cephalagia, 2001, 21 (8): 804~812.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部